In Vivo Toxicology Market 2027 By Product, Testing type and Geography | The Insight Partners

In Vivo Toxicology Market to 2027 - Global Analysis and Forecasts by Product (Instruments, Animal models, Reagents and kits); Testing type (Chronic toxicity testing, Sub-chronic toxicity testing, Sub-acute toxicity testing, Acute toxicity testing); Toxicity endpoint (Immunotoxicity, Systemic toxicity, Carcinogenicity, Genotoxicity, Developmental and reproductive toxicity (DART)) and Geography

Report Code: TIPRE00004418 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
In vivo toxicology testing is used to understand the biological response of individual body to toxin exposure. In vivo toxicology assists in minimizing the adverse effects of molecules within the body, during the development process of new drugs. Animals are used to test the toxicity of chemicals. In vivo toxicology is also used to test the response of the immune system to toxic substances like industrial and environmental chemicals.

MARKET DYNAMICS
Stringent animal testing regulations, rise in pharmaceutical and oncology research and development activities, rising focus on personalized medicine, and innovations in animal models are few of the factors driving the global in vivo toxicology market. Furthermore, the technological advancements in vivo toxicology tests will also further drive the global in vivo toxicology market. However, loopholes in animal testing and growing demand to undertake substitute animal testing methods are few of the factors may restrain the growth of global in vivo toxicology market.

The number of clinical trials are growing. For instance, according to the ClinicalTrials.gov, a total of 281,305 studies are registered on their database as of August 2018.

MARKET SCOPE
The "Global In Vivo Toxicology Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of In Vivo Toxicology market with detailed market segmentation by product, testing type, toxicity endpoint and geography. The global In Vivo Toxicology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading In Vivo Toxicology market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global In Vivo Toxicology market is segmented on the basis of product, testing type, and toxicity endpoint. Based on products, the market is segmented as instruments, animal models, and reagents & kits. Animal models segment is further divided into mice model, rat model and other animal model. On the basis of testing type, the global In Vivo Toxicology market is segmented into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. Based on toxicity endpoint, the market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental and reproductive toxicity (DART).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global In Vivo Toxicology market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The In Vivo Toxicology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting In Vivo Toxicology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the In Vivo Toxicology market in these regions.

MARKET PLAYERS
The reports cover key developments in the In Vivo Toxicology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from In Vivo Toxicology market are anticipated to lucrative growth opportunities in the future with the rising demand for In Vivo Toxicology in the global market. Below mentioned is the list of few companies engaged in the In Vivo Toxicology market.

The report also includes the profiles of key In Vivo Toxicology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Thermo Fisher Scientific
  • Danaher
  • Charles River Laboratories
  • Labcorp
  • The Jackson Laboratory
  • Data Sciences International
  • Envigo
  • Eurofins Scientific
  • Perkinelmer
  • SRI International
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 In Vivo Toxicology Market - By Product
1.3.2 In Vivo Toxicology Market - By Testing type
1.3.3 In Vivo Toxicology Market - By Toxicity endpoint
1.3.4 In Vivo Toxicology Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. IN VIVO TOXICOLOGY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IN VIVO TOXICOLOGY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IN VIVO TOXICOLOGY MARKET - GLOBAL MARKET ANALYSIS
6.1. IN VIVO TOXICOLOGY - GLOBAL MARKET OVERVIEW
6.2. IN VIVO TOXICOLOGY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. IN VIVO TOXICOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. ANIMAL MODELS
7.4.1. Overview
7.4.2. Animal models Market Forecast and Analysis
7.4.3. Mice model Market
7.4.3.1. Overview
7.4.3.2. Mice model Market Forecast and Analysis
7.4.4. Rat model Market
7.4.4.1. Overview
7.4.4.2. Rat model Market Forecast and Analysis
7.4.5. Other animal model Market
7.4.5.1. Overview
7.4.5.2. Other animal model Market Forecast and Analysis
7.5. REAGENTS AND KITS
7.5.1. Overview
7.5.2. Reagents and kits Market Forecast and Analysis
8. IN VIVO TOXICOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - TESTING TYPE
8.1. OVERVIEW
8.2. TESTING TYPE MARKET FORECASTS AND ANALYSIS
8.3. CHRONIC TOXICITY TESTING
8.3.1. Overview
8.3.2. Chronic toxicity testing Market Forecast and Analysis
8.4. SUB-CHRONIC TOXICITY TESTING
8.4.1. Overview
8.4.2. Sub-chronic toxicity testing Market Forecast and Analysis
8.5. SUB-ACUTE TOXICITY TESTING
8.5.1. Overview
8.5.2. Sub-acute toxicity testing Market Forecast and Analysis
8.6. ACUTE TOXICITY TESTING
8.6.1. Overview
8.6.2. Acute toxicity testing Market Forecast and Analysis
9. IN VIVO TOXICOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - TOXICITY ENDPOINT
9.1. OVERVIEW
9.2. TOXICITY ENDPOINT MARKET FORECASTS AND ANALYSIS
9.3. IMMUNOTOXICITY
9.3.1. Overview
9.3.2. Immunotoxicity Market Forecast and Analysis
9.4. SYSTEMIC TOXICITY
9.4.1. Overview
9.4.2. Systemic toxicity Market Forecast and Analysis
9.5. CARCINOGENICITY
9.5.1. Overview
9.5.2. Carcinogenicity Market Forecast and Analysis
9.6. GENOTOXICITY
9.6.1. Overview
9.6.2. Genotoxicity Market Forecast and Analysis
9.7. DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART)
9.7.1. Overview
9.7.2. Developmental and reproductive toxicity (DART) Market Forecast and Analysis
10. IN VIVO TOXICOLOGY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America In Vivo Toxicology Market Overview
10.1.2 North America In Vivo Toxicology Market Forecasts and Analysis
10.1.3 North America In Vivo Toxicology Market Forecasts and Analysis - By Product
10.1.4 North America In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.1.5 North America In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.1.6 North America In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.1.6.1 United States In Vivo Toxicology Market
10.1.6.1.1 United States In Vivo Toxicology Market by Product
10.1.6.1.2 United States In Vivo Toxicology Market by Testing type
10.1.6.1.3 United States In Vivo Toxicology Market by Toxicity endpoint
10.1.6.2 Canada In Vivo Toxicology Market
10.1.6.2.1 Canada In Vivo Toxicology Market by Product
10.1.6.2.2 Canada In Vivo Toxicology Market by Testing type
10.1.6.2.3 Canada In Vivo Toxicology Market by Toxicity endpoint
10.1.6.3 Mexico In Vivo Toxicology Market
10.1.6.3.1 Mexico In Vivo Toxicology Market by Product
10.1.6.3.2 Mexico In Vivo Toxicology Market by Testing type
10.1.6.3.3 Mexico In Vivo Toxicology Market by Toxicity endpoint
10.2. EUROPE
10.2.1 Europe In Vivo Toxicology Market Overview
10.2.2 Europe In Vivo Toxicology Market Forecasts and Analysis
10.2.3 Europe In Vivo Toxicology Market Forecasts and Analysis - By Product
10.2.4 Europe In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.2.5 Europe In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.2.6 Europe In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.2.6.1 Germany In Vivo Toxicology Market
10.2.6.1.1 Germany In Vivo Toxicology Market by Product
10.2.6.1.2 Germany In Vivo Toxicology Market by Testing type
10.2.6.1.3 Germany In Vivo Toxicology Market by Toxicity endpoint
10.2.6.2 France In Vivo Toxicology Market
10.2.6.2.1 France In Vivo Toxicology Market by Product
10.2.6.2.2 France In Vivo Toxicology Market by Testing type
10.2.6.2.3 France In Vivo Toxicology Market by Toxicity endpoint
10.2.6.3 Italy In Vivo Toxicology Market
10.2.6.3.1 Italy In Vivo Toxicology Market by Product
10.2.6.3.2 Italy In Vivo Toxicology Market by Testing type
10.2.6.3.3 Italy In Vivo Toxicology Market by Toxicity endpoint
10.2.6.4 Spain In Vivo Toxicology Market
10.2.6.4.1 Spain In Vivo Toxicology Market by Product
10.2.6.4.2 Spain In Vivo Toxicology Market by Testing type
10.2.6.4.3 Spain In Vivo Toxicology Market by Toxicity endpoint
10.2.6.5 United Kingdom In Vivo Toxicology Market
10.2.6.5.1 United Kingdom In Vivo Toxicology Market by Product
10.2.6.5.2 United Kingdom In Vivo Toxicology Market by Testing type
10.2.6.5.3 United Kingdom In Vivo Toxicology Market by Toxicity endpoint
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific In Vivo Toxicology Market Overview
10.3.2 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis
10.3.3 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.3.5 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.3.6 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.3.6.1 Australia In Vivo Toxicology Market
10.3.6.1.1 Australia In Vivo Toxicology Market by Product
10.3.6.1.2 Australia In Vivo Toxicology Market by Testing type
10.3.6.1.3 Australia In Vivo Toxicology Market by Toxicity endpoint
10.3.6.2 China In Vivo Toxicology Market
10.3.6.2.1 China In Vivo Toxicology Market by Product
10.3.6.2.2 China In Vivo Toxicology Market by Testing type
10.3.6.2.3 China In Vivo Toxicology Market by Toxicity endpoint
10.3.6.3 India In Vivo Toxicology Market
10.3.6.3.1 India In Vivo Toxicology Market by Product
10.3.6.3.2 India In Vivo Toxicology Market by Testing type
10.3.6.3.3 India In Vivo Toxicology Market by Toxicity endpoint
10.3.6.4 Japan In Vivo Toxicology Market
10.3.6.4.1 Japan In Vivo Toxicology Market by Product
10.3.6.4.2 Japan In Vivo Toxicology Market by Testing type
10.3.6.4.3 Japan In Vivo Toxicology Market by Toxicity endpoint
10.3.6.5 South Korea In Vivo Toxicology Market
10.3.6.5.1 South Korea In Vivo Toxicology Market by Product
10.3.6.5.2 South Korea In Vivo Toxicology Market by Testing type
10.3.6.5.3 South Korea In Vivo Toxicology Market by Toxicity endpoint
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa In Vivo Toxicology Market Overview
10.4.2 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis
10.4.3 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.4.5 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.4.6 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa In Vivo Toxicology Market
10.4.6.1.1 South Africa In Vivo Toxicology Market by Product
10.4.6.1.2 South Africa In Vivo Toxicology Market by Testing type
10.4.6.1.3 South Africa In Vivo Toxicology Market by Toxicity endpoint
10.4.6.2 Saudi Arabia In Vivo Toxicology Market
10.4.6.2.1 Saudi Arabia In Vivo Toxicology Market by Product
10.4.6.2.2 Saudi Arabia In Vivo Toxicology Market by Testing type
10.4.6.2.3 Saudi Arabia In Vivo Toxicology Market by Toxicity endpoint
10.4.6.3 U.A.E In Vivo Toxicology Market
10.4.6.3.1 U.A.E In Vivo Toxicology Market by Product
10.4.6.3.2 U.A.E In Vivo Toxicology Market by Testing type
10.4.6.3.3 U.A.E In Vivo Toxicology Market by Toxicity endpoint
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America In Vivo Toxicology Market Overview
10.5.2 South and Central America In Vivo Toxicology Market Forecasts and Analysis
10.5.3 South and Central America In Vivo Toxicology Market Forecasts and Analysis - By Product
10.5.4 South and Central America In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.5.5 South and Central America In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.5.6 South and Central America In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil In Vivo Toxicology Market
10.5.6.1.1 Brazil In Vivo Toxicology Market by Product
10.5.6.1.2 Brazil In Vivo Toxicology Market by Testing type
10.5.6.1.3 Brazil In Vivo Toxicology Market by Toxicity endpoint
10.5.6.2 Argentina In Vivo Toxicology Market
10.5.6.2.1 Argentina In Vivo Toxicology Market by Product
10.5.6.2.2 Argentina In Vivo Toxicology Market by Testing type
10.5.6.2.3 Argentina In Vivo Toxicology Market by Toxicity endpoint
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. IN VIVO TOXICOLOGY MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DANAHER
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CHARLES RIVER LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. LABCORP
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. THE JACKSON LABORATORY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. DATA SCIENCES INTERNATIONAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ENVIGO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. EUROFINS SCIENTIFIC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PERKINELMER
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SRI INTERNATIONAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Thermo Fisher Scientific
2. Danaher
3. Charles River Laboratories
4. Labcorp
5. The Jackson Laboratory
6. Data Sciences International
7. Envigo
8. Eurofins Scientific
9. Perkinelmer
10. SRI International